The RITA-study -An Open Study to Evaluate the Blood Lipid Lowering Effect of Rosuvastatin Versus Fluvastatin and the Bilateral Interaction Between Everolimus and Rosuvastatin in Renal Transplant Recipients.
Phase of Trial: Phase IV
Latest Information Update: 11 Feb 2014
At a glance
- Drugs Rosuvastatin (Primary) ; Everolimus; Fluvastatin
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics; Therapeutic Use
- Acronyms RITA
- 01 Oct 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Sep 2012 Planned End Date changed from 1 Sep 2012 to 1 Nov 2012 as reported by ClinicalTrials.gov record.
- 17 Feb 2012 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.